These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 954258)

  • 41. Phase II study of combination cytotoxic chemotherapy in advanced breast cancer: 2 years' followup.
    Carmo-Pereira J; Teles AG; Costa FO; Pimentel P
    Cancer Treat Rep; 1976 Jan; 60(1):107-9. PubMed ID: 187339
    [No Abstract]   [Full Text] [Related]  

  • 42. [Induction chemotherapy in high risk breast cancer. Results of a prospective therapeutic study (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Cohen P; Lagarde C
    Bull Cancer; 1979; 66(1):9-16. PubMed ID: 420953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
    Greenspan EM
    Mt Sinai J Med; 1972; 39(5):435-46. PubMed ID: 4628078
    [No Abstract]   [Full Text] [Related]  

  • 44. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 45. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract]   [Full Text] [Related]  

  • 46. Combination therapy with adriamycin, cyclophosphamide and vicristine for advanced breast cancer supplemented with non cross-resistant combination.
    Jain SP; Pandey UC; Tandon US; Jain KK; Agarwal S
    Indian J Cancer; 1979; 16(3-4):43-6. PubMed ID: 540959
    [No Abstract]   [Full Text] [Related]  

  • 47. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 48. VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.
    Bramwell VH; Howell A; Scarffe H; Crowther D; Sellwood RA
    Cancer Treat Rep; 1982 Nov; 66(11):1999-2000. PubMed ID: 6897207
    [No Abstract]   [Full Text] [Related]  

  • 49. Life with cytostatic drugs.
    Van Dam FS; Linssen AC; Engelsman E; van Benthem J; Hanewald GJ
    Eur J Cancer (1965); 1980; Suppl 1():229-33. PubMed ID: 6947892
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current overview of EORTC clinical trials with tamoxifen.
    Heuson JC
    Cancer Treat Rep; 1976 Oct; 60(10):1463-6. PubMed ID: 1021227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of doxorubicin (adriamycin) in disseminated forms of breast cancer].
    Trofimova NB; Gorbunova VA
    Antibiotiki; 1983 Aug; 28(8):625-8. PubMed ID: 6638976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 54. Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
    Middleton J; Franks D; Buchanan RB; Hall V; Smallwood J; Williams CJ
    Cancer Treat Rep; 1985 Apr; 69(4):373-5. PubMed ID: 3995509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy of advanced breast cancer. Results of a controlled trial comparing two three-drug regimens.
    Chauvergne J; Berlie J; Clavel B; Guerrin J; Gary-Bobo J; Brulé G; Klein T; Pommatau E; Carton M
    Eur J Cancer (1965); 1978 Sep; 14(9):911-7. PubMed ID: 361415
    [No Abstract]   [Full Text] [Related]  

  • 56. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

  • 58. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.